GENEGRAFTS LTD has a total of 15 patent applications. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CANTAB PHARMACEUTICALS RES LTD, CANJI INC and THERION BIOLOG CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 4 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Sugars | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Feld Yair | 15 |
#2 | Marom Shimon | 15 |
#3 | Gepstein Lior | 13 |
#4 | Bresler Tal | 4 |
#5 | Frank Meira | 4 |
#6 | Miari Reem | 4 |
Publication | Filing date | Title |
---|---|---|
AU2007229419A1 | Modification of Neural Network Discharge by Transplantation of Fibroblasts | |
US2008112927A1 | Cells and methods utilizing same for modifying the electrophysiological function of excitable tissues | |
AU2006324847A1 | Polynucleotides and polypeptide of Human KV1.3, compositions comprising same and methods of using same | |
US2005008628A1 | Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues | |
US7294333B1 | Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |